Medicare AdvantageCoverageMedium impact
Skin and Tissue Substitutes - Medicare Advantage (Revised)
Humana·Plastic Surgery, Dermatology, Wound Care +3 more·Medicare Advantage
Effective date
Sep 1, 2026
We identified it
Sep 2, 2026
Summary
Humana Medicare Advantage updated its Skin and Tissue Substitutes coverage policy (Policy HUM-1208-012) effective September 1, 2026. The policy establishes medical necessity criteria and coverage guidelines for bioengineered skin and tissue substitutes (CTPs) across multiple product types, including allogeneic matrices, composite matrices, acellular matrices, and human skin allografts. Billing teams must verify that all skin substitute claims align with specific HCPCS codes and documented indications (breast reconstruction, diabetic foot ulcers, venous leg ulcers, or burns) per the referenced LCDs.
Action Required
By August 1, 2026: Billing team must update claims submission system and prior authorization workflows to enforce the skin and tissue substitute coverage criteria outlined in this policy. (1) Map all seven HCPCS codes (Q4116, Q4151, Q4101, A4100, C1763, Q4122, Q4186) to their specific medical necessity indications in the billing system. (2) Configure system to require documentation of one of four covered indications: breast reconstruction, diabetic foot ulcer (DFU), venous leg ulcer (VLU), or burn treatment. (3) For DFU and VLU claims, implement validation to ensure they reference the applicable LCD/LCA criteria (L36377 for J15/J8/JH/JL/JN jurisdictions; state-specific MACs per table on page 2). (4) Update prior authorization templates to request FDA indication documentation and wound size/application duration per policy. (5) Train billing and claims review staff on the distinction between product types (allogeneic, composite, acellular matrices) and their coverage limitations. Claims submitted without documented medical necessity or referencing non-covered indications will be denied. Effective date is 09/01/2026, but advance system configuration is recommended by 08/01/2026.